These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 24824696)

  • 41. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.
    Decker MW; Brioni JD; Sullivan JP; Buckley MJ; Radek RJ; Raszkiewicz JL; Kang CH; Kim DJ; Giardina WJ; Wasicak JT
    J Pharmacol Exp Ther; 1994 Jul; 270(1):319-28. PubMed ID: 7913497
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protection by pyroglutamic acid and some of its newly synthesized derivatives against glutamate-induced seizures in mice.
    Beani L; Bianchi C; Baraldi PG; Manfredini S; Pollini GP
    Arzneimittelforschung; 1990 Nov; 40(11):1187-91. PubMed ID: 1982209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Creatine decreases convulsions and neurochemical alterations induced by glutaric acid in rats.
    Magni DV; Oliveira MS; Furian AF; Fiorenza NG; Fighera MR; Ferreira J; Mello CF; Royes LF
    Brain Res; 2007 Dec; 1185():336-45. PubMed ID: 17950259
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
    Engin E; Treit D; Dickson CT
    Neuroscience; 2009 Jun; 161(2):359-69. PubMed ID: 19321151
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhalation of coriander volatile oil increased anxiolytic-antidepressant-like behaviors and decreased oxidative status in beta-amyloid (1-42) rat model of Alzheimer's disease.
    Cioanca O; Hritcu L; Mihasan M; Trifan A; Hancianu M
    Physiol Behav; 2014 May; 131():68-74. PubMed ID: 24747275
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anticonvulsant and neuroprotective effects of the novel nootropic agent nefiracetam on kainic acid-induced seizures in rats.
    Kitano Y; Komiyama C; Makino M; Takasuna K; Satoh H; Aoki T; Kinoshita M; Takazawa A; Yamauchi T; Sakurada S
    Brain Res; 2005 Sep; 1057(1-2):168-76. PubMed ID: 16122714
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis of novel pyrazole derivatives and evaluation of their antidepressant and anticonvulsant activities.
    Abdel-Aziz M; Abuo-Rahma Gel-D; Hassan AA
    Eur J Med Chem; 2009 Sep; 44(9):3480-7. PubMed ID: 19268406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The influence of NMDA, a potent agonist of glutamate receptor, on behavioral activity of rats with experimental hyperammonemia evoked by liver failure.
    Fedosiewicz-Wasiluk M; Hoły ZZ; Wiśniewska RJ; Wiśniewski K
    Amino Acids; 2005 Feb; 28(1):111-7. PubMed ID: 15700110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neurotropic effects of L-lysine in formation of pain-induced behavior.
    Severyanova LA; Dolgintsev ME; Bobyntsev II; Kryukov AA
    Bull Exp Biol Med; 2008 May; 145(5):592-4. PubMed ID: 19145289
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Behavioural phenotyping reveals anxiety-like features of SV2A deficient mice.
    Lamberty Y; Detrait E; Leclercq K; Michel A; De Ryck M
    Behav Brain Res; 2009 Mar; 198(2):329-33. PubMed ID: 19041904
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anticonvulsant and behavioral effects of GABA(B) receptor positive modulator CGP7930 in immature rats.
    Mareš P; Tichá K; Mikulecká A
    Epilepsy Behav; 2013 Jul; 28(1):113-20. PubMed ID: 23708148
    [TBL] [Abstract][Full Text] [Related]  

  • 52. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system.
    Hirotsu I; Kihara T; Nakamura S; Hattori Y; Hatta M; Kitakaze Y; Takahama K; Hashimoto Y; Miyata T; Ishihara T
    Arzneimittelforschung; 1988 Oct; 38(10):1398-409. PubMed ID: 3196380
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effects of anxiolytic drugs on rewarding and aversive behaviors induced by intracranial stimulation].
    Gomita Y; Moriyama M; Ichimaru Y; Araki H; Sagara H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Jun; 24(3):111-8. PubMed ID: 15291239
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activation of adenosine A(1) receptors alters behavioral and biochemical parameters in hyperthyroid rats.
    Bruno AN; Fontella FU; Bonan CD; Barreto-Chaves ML; Dalmaz C; Sarkis JJ
    Behav Brain Res; 2006 Feb; 167(2):287-94. PubMed ID: 16257062
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anxiolytic and anticonvulsant activity of methanol extract of leaves of Alternanthera brasiliana (L.) Kuntze (Amaranthaceae) in laboratory animals.
    Barua CC; Begum SA; Barua AG; Borah RS; Lahkar M
    Indian J Exp Biol; 2013 Jun; 51(6):450-7. PubMed ID: 23926693
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effects of diazepam on the behavioral structure of the rat's response to pain in the hot-plate test: anxiolysis vs. pain modulation.
    Casarrubea M; Sorbera F; Santangelo A; Crescimanno G
    Neuropharmacology; 2012 Aug; 63(2):310-21. PubMed ID: 22521500
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The relationship between anticonvulsant and anti-anxiety effects of calcium channel blockers].
    Kozlovskiĭ VL
    Eksp Klin Farmakol; 1997; 60(5):19-22. PubMed ID: 9483399
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anticonvulsant drug effects in the direct cortical ramp-stimulation model in rats: comparison with conventional seizure models.
    Krupp E; Löscher W
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1137-49. PubMed ID: 9618416
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacology of lorazepam.
    Gluckman MI; Stein L
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):3-10. PubMed ID: 30764
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders.
    Stemmelin J; Cohen C; Terranova JP; Lopez-Grancha M; Pichat P; Bergis O; Decobert M; Santucci V; Françon D; Alonso R; Stahl SM; Keane P; Avenet P; Scatton B; le Fur G; Griebel G
    Neuropsychopharmacology; 2008 Feb; 33(3):574-87. PubMed ID: 17460614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.